YU43556B - Process for obtaining 5-(substituted phenyl)-hydantoins - Google Patents

Process for obtaining 5-(substituted phenyl)-hydantoins

Info

Publication number
YU43556B
YU43556B YU2167/83A YU216783A YU43556B YU 43556 B YU43556 B YU 43556B YU 2167/83 A YU2167/83 A YU 2167/83A YU 216783 A YU216783 A YU 216783A YU 43556 B YU43556 B YU 43556B
Authority
YU
Yugoslavia
Prior art keywords
hydantoins
obtaining
substituted phenyl
phenyl
substituted
Prior art date
Application number
YU2167/83A
Other languages
English (en)
Other versions
YU216783A (en
Inventor
J P Rizzi
R C Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of YU216783A publication Critical patent/YU216783A/xx
Publication of YU43556B publication Critical patent/YU43556B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YU2167/83A 1982-11-01 1983-10-31 Process for obtaining 5-(substituted phenyl)-hydantoins YU43556B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/438,199 US4452806A (en) 1982-11-01 1982-11-01 Treating diabetic complications with 5-(substituted phenyl)hydantoins

Publications (2)

Publication Number Publication Date
YU216783A YU216783A (en) 1986-02-28
YU43556B true YU43556B (en) 1989-08-31

Family

ID=23739660

Family Applications (1)

Application Number Title Priority Date Filing Date
YU2167/83A YU43556B (en) 1982-11-01 1983-10-31 Process for obtaining 5-(substituted phenyl)-hydantoins

Country Status (13)

Country Link
US (1) US4452806A (da)
JP (1) JPS5998063A (da)
KR (1) KR860001507B1 (da)
CA (1) CA1203241A (da)
DK (1) DK158724C (da)
ES (1) ES8507119A1 (da)
FI (1) FI80265C (da)
GR (1) GR79638B (da)
HU (1) HU191887B (da)
PL (1) PL139646B1 (da)
PT (1) PT77578A (da)
YU (1) YU43556B (da)
ZA (1) ZA838092B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7855342B2 (en) 2000-09-25 2010-12-21 Ibiden Co., Ltd. Semiconductor element, method of manufacturing semiconductor element, multi-layer printed circuit board, and method of manufacturing multi-layer printed circuit board
IT1319201B1 (it) * 2000-10-12 2003-09-26 Nicox Sa Farmaci per il diabete.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2814256A1 (de) * 1977-04-05 1978-10-12 Ciba Geigy Ag Schmieroelzusatzstoffe
FR2458546A1 (fr) * 1979-06-07 1981-01-02 Hoechst France Procede de fabrication d'aryl-5 hydantoines racemiques et produits nouveaux en resultant

Also Published As

Publication number Publication date
DK499983A (da) 1984-05-02
ES526841A0 (es) 1985-05-01
ZA838092B (en) 1985-06-26
CA1203241A (en) 1986-04-15
FI80265B (fi) 1990-01-31
PL244350A1 (en) 1985-02-13
JPH0465832B2 (da) 1992-10-21
KR860001507B1 (ko) 1986-09-30
US4452806A (en) 1984-06-05
FI833993A (fi) 1984-05-02
YU216783A (en) 1986-02-28
DK499983D0 (da) 1983-11-01
HU191887B (en) 1987-04-28
PL139646B1 (en) 1987-02-28
FI833993A0 (fi) 1983-10-31
JPS5998063A (ja) 1984-06-06
DK158724B (da) 1990-07-09
GR79638B (da) 1984-10-31
ES8507119A1 (es) 1985-05-01
KR840006630A (ko) 1984-12-01
PT77578A (en) 1983-11-01
FI80265C (fi) 1990-05-10
DK158724C (da) 1990-11-19

Similar Documents

Publication Publication Date Title
EG17031A (en) Novel heterocyclic compounds
GB2119801B (en) Heterocyclic compounds
YU139281A (en) Process for preparing heterocyclic compounds
PH19908A (en) 3-(2-loweralkylamino)alkyl)-n-alkyl-1h-indole-5-methanesulphonomide
PT73503A (en) Process for preparing heterocyclic compounds
YU56881A (en) Process for preparing new heterocyclic compounds
GB8300095D0 (en) Heterocyclic compounds
PT76791A (en) Heterocyclic compounds
PH18045A (en) 5-(substituted phenyl)hydantoins
YU161184A (en) Process for obtaining substituted phenyl carbamate
BG35897A3 (en) Method for preparing 5- (dihydroxy- phenoxy)- 1h- tetrazoles
YU80281A (en) Process for obtaining substituted triarylthiazole compounds
DE3377060D1 (en) Heterocyclic compounds
YU216883A (en) Process for obtaining 5-(2-alkoxy--substituted phenyl)-hydantoins
YU114382A (en) Process for obtaining basically substituted phenyl acetonitriles
YU216783A (en) Process for obtaining 5-(substituted phenyl)-hydantoins
YU180383A (en) Process for obtaining substituted 1-pyridiloxi-3-indolylalkylamino-2-propanole
ZA834032B (en) Heterocyclic compounds
GB8308866D0 (en) Heterocyclic compounds
GB8304744D0 (en) Heterocyclic compounds
PL233021A1 (en) Process for preparing novel 3-/2-hydroxy-4-/substituted/phenyl/-4- or 5-/substituted-cycloalkanes
ZA831466B (en) Heterocyclic compounds
YU306781A (en) Process for obtaining new latam compounds
DE3369985D1 (en) Method for preparing 1,2,3-trihetero 5-membered heterocyclic compounds
DE3368614D1 (en) 5-(substituted phenyl) hydantoins